Literature DB >> 10531294

P48 major surface antigen of Mycoplasma agalactiae is homologous to a malp product of Mycoplasma fermentans and belongs to a selected family of bacterial lipoproteins.

S Rosati1, S Pozzi, P Robino, B Montinaro, A Conti, M Fadda, M Pittau.   

Abstract

A major surface antigenic lipoprotein of Mycoplasma agalactiae, promptly recognized by the host's immune system, was characterized. The mature product, P48, showed significant similarity and shared conserved amino acid motifs with lipoproteins or predicted lipoproteins from Mycoplasma fermentans, Mycoplasma hyorhinis, relapsing fever Borrelia spp., Bacillus subtilis, and Treponema pallidum.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10531294      PMCID： PMC97020     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  39 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  CLUSTAL V: improved software for multiple sequence alignment.

Authors:  D G Higgins; A J Bleasby; R Fuchs
Journal:  Comput Appl Biosci       Date:  1992-04

3.  Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes.

Authors:  M Matsumoto; M Nishiguchi; S Kikkawa; H Nishimura; S Nagasawa; T Seya
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

Review 4.  Genetic mechanisms of bacterial antigenic variation.

Authors:  H S Seifert; M So
Journal:  Microbiol Rev       Date:  1988-09

5.  Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of Mycoplasma gallisepticum.

Authors:  P F Markham; M D Glew; K G Whithear; I D Walker
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

7.  Differential protein expression and surface presentation generate high-frequency antigenic variation in Mycoplasma fermentans.

Authors:  P M Theiss; M F Kim; K S Wise
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  The Vlp system of Mycoplasma hyorhinis: combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation.

Authors:  R Rosengarten; K S Wise
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

9.  Cytoadhesins of Mycoplasma hominis.

Authors:  B Henrich; R C Feldmann; U Hadding
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  A 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes.

Authors:  D A Kostyal; G H Butler; D H Beezhold
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441
View more
  16 in total

1.  Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae.

Authors:  M D Glew; L Papazisi; F Poumarat; D Bergonier; R Rosengarten; C Citti
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Surface diversity in Mycoplasma agalactiae is driven by site-specific DNA inversions within the vpma multigene locus.

Authors:  Michelle D Glew; Marc Marenda; Renate Rosengarten; Christine Citti
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

3.  Development of a sensitive and specific enzyme-linked immunosorbent assay based on recombinant antigens for rapid detection of antibodies against Mycoplasma agalactiae in sheep.

Authors:  Marisa Fusco; Lucia Corona; Toniangelo Onni; Elisabetta Marras; Carla Longheu; Graziano Idini; Sebastiana Tola
Journal:  Clin Vaccine Immunol       Date:  2007-02-07

4.  Molecular cloning and expression of a surface lipoprotein of Mycoplasma capricolum as a potential antigen for serological diagnosis.

Authors:  P Robino; A Alberti; B Chessa; M Pittau; M Profiti; S Rosati
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

5.  Homologue of macrophage-activating lipoprotein in Mycoplasma gallisepticum is not essential for growth and pathogenicity in tracheal organ cultures.

Authors:  Philip F Markham; Anna Kanci; György Czifra; Bo Sundquist; Peter Hains; Glenn F Browning
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

6.  Characterization and analysis of a stable serotype-associated membrane protein (P30) of Mycoplasma agalactiae.

Authors:  B Fleury; D Bergonier; X Berthelot; Y Schlatter; J Frey; E M Vilei
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

7.  Proteomics and pathway analyses of the milk fat globule in sheep naturally infected by Mycoplasma agalactiae provide indications of the in vivo response of the mammary epithelium to bacterial infection.

Authors:  Maria Filippa Addis; Salvatore Pisanu; Stefania Ghisaura; Daniela Pagnozzi; Gavino Marogna; Alessandro Tanca; Grazia Biosa; Carla Cacciotto; Alberto Alberti; Marco Pittau; Tonina Roggio; Sergio Uzzau
Journal:  Infect Immun       Date:  2011-06-20       Impact factor: 3.441

8.  Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans.

Authors:  Kelley L Davis; Kim S Wise
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

9.  Critical role of dispensable genes in Mycoplasma agalactiae interaction with mammalian cells.

Authors:  Eric Baranowski; Sébastien Guiral; Eveline Sagné; Agnès Skapski; Christine Citti
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

10.  The liposoluble proteome of Mycoplasma agalactiae: an insight into the minimal protein complement of a bacterial membrane.

Authors:  Carla Cacciotto; Maria Filippa Addis; Daniela Pagnozzi; Bernardo Chessa; Elisabetta Coradduzza; Laura Carcangiu; Sergio Uzzau; Alberto Alberti; Marco Pittau
Journal:  BMC Microbiol       Date:  2010-08-25       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.